The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients
Conditions: Migraine; Migraine Without Aura; Migraine With Aura Interventions: Drug: Erenumab; Drug: Placebo; Drug: Calcitonin gene-related peptide; Drug: Cilostazol Sponsors: Danish Headache Center; Novartis Pharmaceuticals Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials